INIA Biosciences

INIA Biosciences, founded in 2018 and based in San Diego, is pioneering a novel approach to bioelectronic medicine by harnessing ultrasound technology. The company is developing non-invasive, home-use medical devices designed to treat chronic inflammatory diseases through immune system modulation. As a private, pre-revenue startup, it is in the pre-clinical stage, building its team and technology platform with advisors from the medical device and venture capital sectors. Its vision is to redefine treatment paradigms by offering a drug-free, precision alternative for chronic disease management.

Ultrasound-based bioelectronic platform for non-invasive, closed-loop modulation of the immune system. Aims to enable home-administered treatment for chronic inflammatory diseases.

INIA competes with established pharmaceutical companies developing biologic and small molecule drugs for immunology/oncology, and with other bioelectronic medicine startups (e.g., those focused on vagus nerve stimulation). Its differentiation is the specific use of non-invasive ultrasound.